Category: Avandia

WARNING ON AVANDIA ♦ INCREASED RISK OF HEART ATTACK ♦

NATIONAL – In a recent article in the New England Journal of Medicine announced that, finally, the FDA has stepped forward and decided on regulatory action for Avandia, a diabetes drug that last year claimed 1,354 lives as a result of cardiac-associated problems. The FDA is restricting access to Avandia by requiring GSK to submit…

PATIENTS AT RISK | Avandia | FDA approval | GSK

NATIONAL – According to TIME (8/12, Park) reports that the FDA panel’s recent decision to recommend keeping Avandia (rosiglitazone) on the market is “a move worth billions of dollars to GSK but that also may have put millions of patients at risk.” The move is also an example “of the drug industry’s outmaneuvering FDA regulators,”…